nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0605	0.0627	CcSEcCtD
Tadalafil—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0481	0.0498	CcSEcCtD
Tadalafil—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0241	0.0249	CcSEcCtD
Tadalafil—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0236	0.0244	CcSEcCtD
Tadalafil—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0234	0.0242	CcSEcCtD
Tadalafil—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0229	0.0238	CcSEcCtD
Tadalafil—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0222	0.023	CcSEcCtD
Tadalafil—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.0193	0.02	CcSEcCtD
Tadalafil—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0173	0.0179	CcSEcCtD
Tadalafil—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0171	0.0178	CcSEcCtD
Tadalafil—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0176	CcSEcCtD
Tadalafil—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0164	0.017	CcSEcCtD
Tadalafil—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.0168	CcSEcCtD
Tadalafil—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0167	CcSEcCtD
Tadalafil—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0156	CcSEcCtD
Tadalafil—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.0145	CcSEcCtD
Tadalafil—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0144	CcSEcCtD
Tadalafil—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0141	CcSEcCtD
Tadalafil—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0133	0.0137	CcSEcCtD
Tadalafil—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0132	CcSEcCtD
Tadalafil—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0132	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0128	CcSEcCtD
Tadalafil—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0123	CcSEcCtD
Tadalafil—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0123	CcSEcCtD
Tadalafil—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0121	CcSEcCtD
Tadalafil—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.012	CcSEcCtD
Tadalafil—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.012	CcSEcCtD
Tadalafil—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0119	CcSEcCtD
Tadalafil—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0119	CcSEcCtD
Tadalafil—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0117	CcSEcCtD
Tadalafil—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0116	CcSEcCtD
Tadalafil—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0111	CcSEcCtD
Tadalafil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.011	CcSEcCtD
Tadalafil—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.011	CcSEcCtD
Tadalafil—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0109	CcSEcCtD
Tadalafil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0109	CcSEcCtD
Tadalafil—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0109	CcSEcCtD
Tadalafil—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0108	CcSEcCtD
Tadalafil—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0108	CcSEcCtD
Tadalafil—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0099	0.0103	CcSEcCtD
Tadalafil—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00985	0.0102	CcSEcCtD
Tadalafil—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00963	0.00998	CcSEcCtD
Tadalafil—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00956	0.00991	CcSEcCtD
Tadalafil—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0093	0.00963	CcSEcCtD
Tadalafil—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.0092	CcSEcCtD
Tadalafil—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00902	CcSEcCtD
Tadalafil—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00844	0.00875	CcSEcCtD
Tadalafil—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.0083	0.0086	CcSEcCtD
Tadalafil—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00806	0.00835	CcSEcCtD
Tadalafil—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.008	0.00829	CcSEcCtD
Tadalafil—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.00827	CcSEcCtD
Tadalafil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00815	CcSEcCtD
Tadalafil—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00815	CcSEcCtD
Tadalafil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00815	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00809	CcSEcCtD
Tadalafil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.00805	CcSEcCtD
Tadalafil—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.00797	CcSEcCtD
Tadalafil—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00754	0.00781	CcSEcCtD
Tadalafil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00749	0.00776	CcSEcCtD
Tadalafil—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00739	0.00766	CcSEcCtD
Tadalafil—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00759	CcSEcCtD
Tadalafil—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.00755	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00712	CcSEcCtD
Tadalafil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.00707	CcSEcCtD
Tadalafil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.00702	CcSEcCtD
Tadalafil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.00697	CcSEcCtD
Tadalafil—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0067	0.00695	CcSEcCtD
Tadalafil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00664	0.00688	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00651	0.00675	CcSEcCtD
Tadalafil—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.00674	CcSEcCtD
Tadalafil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00668	CcSEcCtD
Tadalafil—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00668	CcSEcCtD
Tadalafil—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.00639	CcSEcCtD
Tadalafil—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.00621	CcSEcCtD
Tadalafil—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.00618	CcSEcCtD
Tadalafil—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00576	CcSEcCtD
Tadalafil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.00561	CcSEcCtD
Tadalafil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00533	0.00553	CcSEcCtD
Tadalafil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00535	CcSEcCtD
Tadalafil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00517	CcSEcCtD
Tadalafil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.00497	CcSEcCtD
Tadalafil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00475	0.00493	CcSEcCtD
Tadalafil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00475	0.00492	CcSEcCtD
Tadalafil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.00489	CcSEcCtD
Tadalafil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.00464	CcSEcCtD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.00416	0.119	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.00371	0.106	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0033	0.0944	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.00294	0.0842	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00162	0.0464	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00154	0.0441	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00144	0.0413	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00137	0.0393	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00103	0.0295	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00092	0.0263	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000739	0.0212	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000659	0.0189	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000618	0.0177	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000551	0.0158	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000467	0.0134	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000465	0.0133	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000439	0.0126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000424	0.0121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000422	0.0121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000403	0.0115	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000391	0.0112	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000368	0.0105	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000363	0.0104	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000357	0.0102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000355	0.0102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000341	0.00976	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000328	0.00938	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000324	0.00928	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000324	0.00926	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000306	0.00875	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000305	0.00874	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000303	0.00867	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000275	0.00787	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.0078	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000272	0.00779	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000251	0.00719	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000251	0.00717	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000249	0.00713	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000228	0.00653	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00021	0.006	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000193	0.00553	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000192	0.00548	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000172	0.00493	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000162	0.00465	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000158	0.00451	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000149	0.00427	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000135	0.00386	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000125	0.00357	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.00297	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.94e-05	0.00227	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.55e-05	0.00187	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.58e-05	0.000739	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.27e-05	0.000651	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.1e-05	0.0006	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.58e-05	0.000451	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.35e-05	0.000386	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.03e-05	0.000296	CbGpPWpGaD
